All News
All series
All All News
Advertisement
While breast cancer in young women appears to have similar characteristics, many experts agree that treating the type of breast cancer is more important than focusing on age at this point.
Advertisement
Cost of cancer care is a growing concern of both patients and medical professionals.
Ponatinib continues to make improvements in phase 2 CML study.
Velcade-based therapy shows benefit in multiple myeloma trial called GIMEMA.
A study shows that a chemotherapy-free regimen may be better in acute promyelocytic leukemia.
Find information and resources on Medicare.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
2
Neuroendocrine Tumors: 7 Questions Patients Ask, Answered
3
Why Rituxan Plus Cladribine May Delay Hairy Cell Leukemia Relapse
4
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
5